• PMH20 ECONOMIC BURDEN OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD): A GLOBAL SYSTEMATIC REVIEW

    May 1, 2020, 00:00

  • PIH2 EFFICACY AND SAFETY OF MIDAZOLAM ORAL SOLUTION FOR SEDATIVE-HYPNOSIS AND ANTI-ANXIETY IN CHILDREN: A SYSTEMATIC REVIEW AND META-ANALYSIS

    May 1, 2020, 00:00

  • PIN3 RELATIVE VACCINE EFFECTIVENESS OF QUADRIVALENT CELL-BASED VERSUS EGG-BASED INFLUENZA VACCINES AMONG ADULTS 50-64 YEARS OLD: A U.S. OBSERVATIONAL COHORT STUDY

    May 1, 2020, 00:00

  • PMD14 PREVENTION VERSUS TREATMENT OF VENOUS ULCERS IN BRAZILIAN NATIONAL HEALTH SYSTEM: HOW MUCH COULD BE SAVED?

    May 1, 2020, 00:00

  • PMH64 INPATIENT PRESCRIBING PATTERNS OF LONG-ACTING INJECTABLE ANTIPSYCHOTICS AND THEIR ORAL OR SHORT-ACTING INJECTABLE FORMULATIONS

    May 1, 2020, 00:00

  • PMU22 A SYSTEMATIC REVIEW FOR BURDEN OF DISEASE STUDIES IN CHINA: ARE THERE STILL UNMET NEEDS?

    May 1, 2020, 00:00

  • PDB22 THE DIABETES PREVENTION PROGRAM (DPP) QUALITY OF WELL BEING (QWB) AND SF-6D UTILITY MEASURES AND MISSING DATA CONSIDERATIONS: AVAILABLE CASE ANALYSIS (ACA) VS. MANSKI LOWER AND UPPER BOUNDS (LMB AND UMB) RESULTS FOR UTILITIES AND QUAL ...

    May 1, 2020, 00:00

  • Musculoskeletal Disorders - Health Service Delivery Process of Care

    May 1, 2020, 00:00

  • PDG11 COST MINIMIZATION ANALYSIS OF TRASTUZUMAB SUBCUTANEOUS VERSUS INTRAVENOUS IN TREATMENT OF HER2-POSITIVE EARLY OR METASTATIC BREAST CANCER IN VIETNAM

    May 1, 2020, 00:00

  • PDB41 HOW MUCH DOES THERAPEUTIC INERTIA IN TYPE 2 DIABETES COST THE UK? A MODELING EVALUATION OF ECONOMIC BURDEN

    May 1, 2020, 00:00

  • Mental Health - Clinical Outcomes

    May 1, 2020, 00:00

  • PMH21 PROVIDING THE DEPRESSION CARE FOR PEOPLE WITH CANCER PROGRAM TO PROSTATE CANCER PATIENTS IN THE UNITED STATES: A COST-EFFECTIVENESS ANALYSES

    May 1, 2020, 00:00

  • PMS9 PLACEBO EFFECT IN KNEE OSTEOARTHRITIS: A TARGETED LITERATURE REVIEW ON THE CHALLENGES, HYPOTHESES, AND POTENTIAL SOLUTIONS

    May 1, 2020, 00:00

  • PMD40 FEMTOSECOND LASER ASSISTED CATARACT SURGERY: A REVIEW OF ITS EFFICIENCY COMPARED TO MANUAL CATARACT SURGERY

    May 1, 2020, 00:00

  • Infectious Diseases - Health Technology Assessment

    May 1, 2020, 00:00

  • PDB27 THE DIABETES PREVENTION PROGRAM (DPP) QUALITY OF WELL BEING (QWB) UTILITY MEASURES AND MISSING DATA CONSIDERATIONS: AVAILABLE CASE ANALYSIS (ACA) VS. MANSKI LOWER AND UPPER BOUNDS (LMB AND UMB) RESULTS FOR UTILITIES AND QUALITY ADJUST ...

    May 1, 2020, 00:00

  • PDG39 CHALLENGE OR OPPORTUNITY? THE EXPANSION OF DRUG VOLUME-BASED PROCUREMENT IN CHINA

    May 1, 2020, 00:00

  • PCV61 EFFECTIVENESS OF A CARDIOVASCULAR RISK MANAGEMENT PROGRAM IN REDUCING THE PROBABILITY OF PREMATURE DEATH DUE TO CARDIOVASCULAR EVENTS IN THE COLOMBIAN CARIBBEAN REGION

    May 1, 2020, 00:00

  • PIH68 HEALTH-RELATED QUALITY OF LIFE MEASUREMENTS IN WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00

  • PMH25 CHARACTERISTICS AND HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER CONTINUING, SWITCHING, OR DISCONTINUING THERAPY IN A REAL-WORLD SETTING

    May 1, 2020, 00:00

  • PIH55 TIME TRENDS AND FACTORS PREDICTING ANTICHOLINERGIC MEDICATION PRESCRIBING TO OLDER ADULTS IN THE UNITED STATES

    May 1, 2020, 00:00

  • PCV83 COMPARISON OF TREATMENT ADHERENCE AND PERSISTENCE WITH EDOXABAN VERSUS APIXABAN, DABIGATRAN, RIVAROXABAN, AND VITAMIN K ANTAGONIST IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN GERMANY: A PROPENSITY MATCHED COHORT STUDY

    May 1, 2020, 00:00

  • PCV59 EPIDEMIOLOGICAL DISEASE BURDEN OF ACUTE MYOCARDIAL INFARCTION BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00

  • PDB51 IMPACT OF SENSOR AUGMENTED PUMP (SAP) IN TYPE 1 DIABETES MELLITUS (DMT1) PATIENTS IN COLOMBIA

    May 1, 2020, 00:00

  • PMS54 EPIDEMIOLOGICAL DISEASE BURDEN OF INJURIES TO THE SHOULDER AND UPPER ARM BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00

  • Medical Devices - Real World Data Information Systems

    May 1, 2020, 00:00

  • PDG16 A REVIEW OF THE EVIDENCE ON THE NET MONETARY BENEFIT OF SMOKING CESSATION INTERVENTIONS

    May 1, 2020, 00:00

  • PMS74 THE EXAMINATION OF THE RELATIONSHIP BETWEEN BALANCE AND POSTURAL MUSCLES AMONG ELEMENTARY SCHOOL CHILDREN

    May 1, 2020, 00:00

  • PBI43 REAL-WORLD EVIDENCE RECOMMENDATIONS FOR GENE THERAPIES: REGULATORY VERSUS HEALTH TECHNOLOGY ASSESSMENT

    May 1, 2020, 00:00

  • PCV54 AGE-SPECIFIC EXAMINATION OF EARLY CEREBROVASCULAR MORTALITY: 1990-2014

    May 1, 2020, 00:00

  • PMU64 IS THERE AN ASSOCIATION BETWEEN NON-COMMUNICABLE DISEASE MORTALITY AND CORRUPTION INDEXES? A GLOBAL PERSPECTIVE

    May 1, 2020, 00:00

  • PCN11 REAL-WORLD TREATMENT PATTERNS IN RESECTABLE (STAGE I-IIIA) NON-SMALL CELL LUNG CANCER (NSCLC): A SYSTEMATIC LITERATURE REVIEW (SLR)

    May 1, 2020, 00:00

  • PIN22 MORTALITY, MORBIDITY AND BURDEN OF HOSPITALIZATIONS IN INFLUENZA PATIENTS WITH LOW AND HIGH COMORBIDITY INDEX: A PROPENSITY SCORE MATCHED ANALYSIS OF IN-PATIENT CLAIMS DATABASE

    May 1, 2020, 00:00

  • Cardiovascular Disorders - Health Service Delivery Process of Care

    May 1, 2020, 00:00

  • PMU2 DEVELOPMENT AND USE OF SIMULATION-BASED TOOL INFORMING CLINICAL AND MARKET ACCESS STRATEGY

    May 1, 2020, 00:00

  • PIH17 ECONOMIC IMPACT OF VAGUS NERVE STIMULATION THERAPY IN PEDIATRIC PATIENTS WITH DRUG-RESISTANT EPILEPSY

    May 1, 2020, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Real World Data Information Systems

    May 1, 2020, 00:00

  • PIH39 ASSOCIATION OF HEALTH-RELATED QUALITY OF LIFE AND PASSIVE SMOKE EXPOSURE IN PREGNANCY: EVIDENCE FROM A NATIONAL STUDY

    May 1, 2020, 00:00

  • PBI41 LONGITUDINAL EVALUATION OF PRODUCT UTILIZATION AND CHARACTERISTICS AMONG PATIENTS TREATED WITH BIOLOGIC ANTI-INFLAMMATORY AGENTS: A STUDY BY THE BIOLOGICS AND BIOSIMILARS COLLECTIVE INTELLIGENCE CONSORTIUM

    May 1, 2020, 00:00

  • Copyright/Subscription

    May 1, 2020, 00:00

  • PIH73 INFLUENCE OF MATERNAL MINDFULNESS TRAINING DURING PREGNANCY ON EXECUTIVE ABILITIES IN PRESCHOOL CHILDREN

    May 1, 2020, 00:00

  • PMS72 COMPUTERIZED ADAPTIVE TESTING OF ROUTINELY CAPTURED ORTHOPEDIC PRO MEASURES

    May 1, 2020, 00:00

  • PMS28 COST-UTILITY ANALYSIS OF TREATMENT OPTIONS AFTER INITIAL TUMOR NECROSIS FACTOR INHIBITOR THERAPY FAILURE IN PATIENTS WITH RHEUMATOID ARTHRITIS

    May 1, 2020, 00:00

  • PIH16 ESTIMATING THE VALUE OF NURSING TIME TO REDUCE COSTS AND INCREASE QUALITY OF PRESSURE INJURY PREVENTION IN NURSING HOMES: A COST-EFFECTIVENESS ANALYSIS OF THE TEAM-UP CLINICAL TRIAL

    May 1, 2020, 00:00

  • PDB38 BURDEN OF CARDIOVASCULAR DISEASE AND CARDIOVASCULAR (CV) RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM): AN ANALYSIS OF A US HEALTH INSURANCE DATABASE

    May 1, 2020, 00:00

  • PDB29 A COST-UTILITY ANALYSIS OF SODIUM-GLUCOSE COTRANSPORTER (SGLT) 2 INHIBITORS IN ADDITION TO BASAL-BOLUS INSULIN IN THE TREATMENT OF TYPE 1 DIABETES IN THE USA USING THE PRIME DIABETES MODEL

    May 1, 2020, 00:00

  • PMU36 COST-UTILITY ANALYSIS OF SINGLE DOSE GENE-REPLACEMENT THERAPY FOR SPINAL MUSCULAR ATROPHY TYPE 1 COMPARED TO CHRONIC NUSINERSEN TREATMENT IN JAPAN

    May 1, 2020, 00:00

  • Musculoskeletal Disorders - Patient-Centered Research

    May 1, 2020, 00:00

  • PIN44 SHORTENING TREATMENT FOR MULTIDRUG-RESISTANT TUBERCULOSIS IN BRAZIL: A COST-EFFECTIVENESS ANALYSIS

    May 1, 2020, 00:00

  • PCN3 RETROSPECTIVE ELECTRONIC HEALTH RECORDS STUDY IN THE CANCERLINQ DISCOVERY DATABASE OF TREATMENT PATTERNS AMONG PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

    May 1, 2020, 00:00

  • PMD19 SYSTEMATIC LITERATURE REVIEW TO IDENTIFY THE CURRENT STATE OF KNOWLEDGE REGARDING HOME INFUSION VS MEDICAL-SETTING INFUSION

    May 1, 2020, 00:00

  • PIN64 INFLUENZA VACCINATION STATUS IN AMERICAN INDIANS AND ALASKA NATIVES FOR THE 2018‑2019 INFLUENZA SEASON IN TRINETX ELECTRONIC MEDICAL RECORD DATA

    May 1, 2020, 00:00

  • PIT6 DISCRIMINATIVE ABILITY OF NEW INJURY SEVERITY SCORE TO PREDICT OUTCOMES AFTER FRACTURE REPAIRED SURGERY

    May 1, 2020, 00:00

  • PDG27 OUTPATIENT CEPHALOSPORIN USE IN A COLOMBIAN POPULATION: PRESCRIPTION-INDICATION STUDY

    May 1, 2020, 00:00

  • Drugs Generics - Economic Evaluation

    May 1, 2020, 00:00

  • PMS87 PROGRESSIVE SUBAQUAL TRAINING 3 MONTHS FOLLOW-UP IN FALL PREVENTION OF OSTEOPOROTIC PATIENT

    May 1, 2020, 00:00

  • PMH32 PERCEPTION, PREVALENCE AND FACTORS ASSOCIATED TO SCHOOL BULLYING IN YOUNG PEOPLE FROM A POPULATION AFFILIATED IN A COLOMBIAN HEALTH SUBSIDIZED INSURANCE COMPANY IN 2018.

    May 1, 2020, 00:00

  • PBI26 RAPID REVIEW OF TRASTUZUMAB BIOSIMILARS COMPARED TO REFERENCE TRASTUZUMAB FOR BREAST CANCER TREATMENT IN NAIVE PATIENTS

    May 1, 2020, 00:00

  • PDB43 QUALITY ADJUSTED LIFE YEARS (QALYS) IN THE DIABETES PREVENTION PROGRAM (DPP): QUALITY OF WELL BEING (QWB) VERSUS SF-6D INSTRUMENTS

    May 1, 2020, 00:00

  • PDB16 A POPULATION-ADJUSTED INDIRECT COMPARISON OF CARDIOVASCULAR BENEFITS BETWEEN ONCE-WEEKLY SEMAGLUTIDE AND DULAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES AND HIGH CARDIOVASCULAR RISK

    May 1, 2020, 00:00

  • PMH9 ESTIMATED COST-EFFECTIVENESS OF A 12-WEEK TREATMENT COURSE OF THE FIRST FDA-CLEARED PRESCRIPTION DIGITAL THERAPEUTIC FOR PATIENTS WITH OPIOID USE DISORDER

    May 1, 2020, 00:00

  • PIN24 INCIDENCE AND COSTS OF INFLUENZA-RELATED HOSPITALIZATIONS BY COMORBIDITY IN THE UNITED STATES

    May 1, 2020, 00:00

  • PIH9 BUDGET IMPACT ANALYSIS VS. COST EFFECTIVENESS ANALYSIS - HORMONAL CONTRACEPTIVES AS AN ILLUSTRATIVE CASE

    May 1, 2020, 00:00

  • PIN30 ESTIMATED BUDGET IMPACT OF THE INTRODUCTION OF DOLUTEGRAVIR/LAMIVUDINE (DTG/3TC) IN THE UNITED STATES FOR THE TREATMENT OF HIV INFECTION

    May 1, 2020, 00:00

  • PIN26 ECONOMIC IMPACT IN DOMINICAN REPUBLIC SENASA OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) VERSUS NO VACCINATION IN OLDER ADULTS

    May 1, 2020, 00:00

  • PIN42 COMPARISON OF ECONOMIC BURDEN AND RISK OF HOSPITALIZATION AMONG HIV PATIENTS WITH AND WITHOUT HEPATITIS B COINFECTION IN THE VETERANS HEALTH ADMINISTRATION POPULATION

    May 1, 2020, 00:00

  • PDG31 THE PRICING AND SPENDING TRENDS OF ULTRA-EXPENSIVE DRUGS IN MEDICARE PART D PROGRAM

    May 1, 2020, 00:00

  • PDG25 UTILIZATION OF PRESCRIPTION OPIOIDS AND BENZODIAZEPINES AMONG ARKANSANS WITH MEDICAL CANNABIS IDENTIFICATION CARDS: A MATCHED CONTROL STUDY

    May 1, 2020, 00:00

  • Biologics/Biosimilars/Regenerative Medicine - Epidemiology Public Health

    May 1, 2020, 00:00

  • PCV72 DIFFERENTIAL USE OF TRANSCATHETER AORTIC VALVE IMPLANTS (TAVI). PERSONALIZATION STUDY

    May 1, 2020, 00:00

  • PBI9 BUDGET IMPACT ANALYSIS OF OBINUTUZUMAB-CHEMOTHERAPY FOLLOWED BY OBINUTUZUMAB MAINTENANCE COMPARED TO RITUXIMAB-CHEMOTHERAPY FOLLOWED BY RITUXIMAB MAINTENANCE IN A CHILEAN HEALTH PUBLIC SYSTEM SETTING FOR NON-HODGKIN-LYMPHOMA PATIENTS

    May 1, 2020, 00:00

  • PGI7 EVALUATION OF LIVER OUTCOMES RELATIVE TO USE OF GLP-1 RECEPTOR AGONISTS (GLP1A) AND/OR SGLT-2 INHIBITORS (SGLT2I) IN REAL-WORLD POPULATIONS DIAGNOSED WITH TYPE II DIABETES (T2DM) AND NASH/NAFLD OR AT RISK OF NASH

    May 1, 2020, 00:00

  • PIN75 IMMUNIZATIONS AND INJECTABLE MEDICATIONS: PHARMACISTS' INTEREST, ENGAGEMENT, AND REIMBURSEMENT PATTERNS IN MISSISSIPPI

    May 1, 2020, 00:00

  • PDB13 ASSOCIATION OF VERAPAMIL THERAPY AND REDUCED HYPOGLYCEMIC EVENTS AMONG MEDICARE PATIENTS WITH NEWLY DIAGNOSED TYPE 1 DIABETES

    May 1, 2020, 00:00

  • PMU23 QUANTIFYING THE COSTS OF OBESITY-RELATED COMPLICATIONS IN THE UNITED STATES: A RETROSPECTIVE DATABASE STUDY

    May 1, 2020, 00:00

  • PBI16 COST ANALYSIS OF TWO TREATMENTS BY INFLIXIMAB (ORIGINATOR AND BIOSIMILAR) FOR PATIENTS WITH RHUMATOÏD ARTHRITIS (RA) OR INFLAMMATORY BOWEL DISEASE (IBD) IN A GROUP OF FRENCH PUBLIC HOSPITALS (UNIHA)

    May 1, 2020, 00:00

  • Infectious Diseases - Clinical Outcomes

    May 1, 2020, 00:00

  • Alternative Medicine Nutrition - Patient-Centered Research

    May 1, 2020, 00:00

  • PMU4 EVIDENCE FOR THE USABILITY OF THE E-TSQM

    May 1, 2020, 00:00

  • PDB56 CONTRASTING THREE TYPE 2 DIABETES CARDIOVASCULAR RISK EQUATIONS FOR EAST ASIA WITH UKPDS82 USING THE IQVIA CORE DIABETES MODEL

    May 1, 2020, 00:00

  • PDB45 THE BUDGET IMPACT OF SITAGLIPTIN VERSUS ORAL SEMAGLUTIDE FROM A US PAYER PERSPECTIVE

    May 1, 2020, 00:00

  • Informing Patient-Centered Care Through Stakeholder Engagement and Highly Stratified Quantitative Benefit–Harm Assessments [Editor's Choice]

    May 1, 2020, 00:00

  • Mental Health - Epidemiology Public Health

    May 1, 2020, 00:00

  • Injury Statistical Research

    May 1, 2020, 00:00

  • PMS18 ANNUAL HEALTH INSURANCE TREATMENT COST OF INJURIES TO THE SHOULDER AND UPPER ARM BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00

  • PIH23 A CLINICAL AND ECONOMIC ANALYSIS OF THE SINGLE-DOSE VERSUS MULTIPLE-DOSE APPROACHES OF SURFACTANT USE IN MECONIUM ASPIRATION SYNDROME IN NEONATAL INTENSIVE CARE UNITS IN QATAR

    May 1, 2020, 00:00

  • Individual's Health - Health Service Delivery Process of Care

    May 1, 2020, 00:00

  • Injury Trauma - Economic Evaluation

    May 1, 2020, 00:00

  • PGI3 LEAN AND OBESE PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) / NON-ALCOHOLIC FATTY LIVER DISEASE (NALFD); COMPARISONS OF POPULATIONS AND DISEASE PROGRESSION

    May 1, 2020, 00:00

  • PIH3 ANGIOTENSIN I CONVERTING ENZYME INHIBITORS REDUCE RISK OF PNEUMONIA IN HOSPITALIZED ELDERLY PATIENTS

    May 1, 2020, 00:00

  • PMH71 VALUE-BASED HEALTHCARE: CAN ARTIFICIAL INTELLIGENCE IMPROVE THE MENTAL HEALTH WITH BRAZILIAN DATA?

    May 1, 2020, 00:00

  • PIN2 REAL-WORLD EFFECTIVENESS OF HEPATITIS C VIRUS (HCV) TREATMENT WITH DIRECT-ACTING ANTIVIRALS (DAA) IN POPULATIONS WITH FATTY LIVER/NON-ALCOHOLIC STEATOHEPATITIS (FL/NASH), DECOMPENSATED CIRRHOSIS (DCC), HEPATOCELLULAR CARCINOMA (HCC), A ...

    May 1, 2020, 00:00

  • PMS11 MEDICAL RESOURCE USE IN PATIENTS WITH PSORIATIC ARTHRITIS IN A COMPREHENSIVE RHEUMATOLOGICAL CENTER IN COLOMBIA

    May 1, 2020, 00:00

  • PMS76 ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS OF KNEE OSTEOARTHRITIS IN QUETTA, PAKISTAN

    May 1, 2020, 00:00

  • PDG18 DIFFERENCES IN RESOURCE UTILIZATION AND COSTS BETWEEN NARCOTIC USERS AND NON-NARCOTIC USERS FROM THE 2017 MEDICAL EXPENDITURE PANEL SURVEY

    May 1, 2020, 00:00

  • PGI22 ESTIMATING DIAGNOSTIC COSTS ASSOCIATED WITH A SECOND-GENERATION BLOOD TEST FOR ANTI-VINCULIN AND ANTI-CYTOLETHAL DISTENDING TOXIN B (CDTB) BIOMARKERS IN COMPARISON TO THE STANDARD EXCLUSIONARY APPROACH FOR IRRITABLE BOWEL SYNDROME WIT ...

    May 1, 2020, 00:00

  • PMS33 BUDGET IMPACT ANALYSIS OF KNEE JOINT REPLACEMENT DELAY IN PATIENTS WITH SEVERE KNEE OSTEOARTHRITIS TREATED WITH HYLAN GF-20, LOW MOLECULAR WEIGHT HYALURONATES AND CORTICOSTEROIDS IN COLOMBIA

    May 1, 2020, 00:00

  • PDG4 DESCRIPTION OF PRESCRIPTION OPIOID USE AMONG US ADULTS

    May 1, 2020, 00:00

  • PDG71 DOES LIPID LOWERING THERAPY UP-TITRATION IN OLDER ADULTS IMPACT ADHERENCE?

    May 1, 2020, 00:00

  • PIN54 MODELLING THE EFFECT OF TARGETED TREATMENT IN A TB OUTBREAK WITH COMPLEX CONTAGION

    May 1, 2020, 00:00

  • PGI24 EPISODE OF CARE COSTS ASSOCIATED WITH MINIMALLY INVASIVE COLON SURGERY: A PROPENSITY-MATCHED ANALYSIS USING MEDICARE AND COMMERCIAL CLAIMS DATA

    May 1, 2020, 00:00

  • PMS22 ANNUAL HEALTH INSURANCE TREATMENT COST OF FEMORAL NECK FRACTURE BASED ON ROUTINELY COLLECTED, REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00

  • PMS36 THE ECONOMIC BURDEN OF FIBROMYALGIA IN CHINA

    May 1, 2020, 00:00

  • PMD20 ECONOMIC IMPACT OF SPECIALIZED LABORATORY AUTOMATION ON THE TURNAROUND TIME (TAT) MEAN AND STANDARD DEVIATION

    May 1, 2020, 00:00

  • PMH28 ANTIPSYCHOTIC DRUG USE AMONG A US NATIONAL COHORT OF OLDER DEMENTIA PATIENTS USING ACETYLCHOLINESTERASE INHIBITORS

    May 1, 2020, 00:00

  • PBI27 TRENDS IN AVERAGE SALES PRICES OF BIOLOGICS REIMBURSED BY THE MEDICARE PART B PROGRAM (FIRST QUARTER 2010-FIRST QUARTER 2020)

    May 1, 2020, 00:00

  • PMS2 RETROSPECTIVE ANALYSIS TO DETERMINE THE INCREASED RISK OF DEVELOPING OSTEOPOROSIS IN PATIENTS DIAGNOSED WITH DEPRESSION AND/OR PRESCRIBED ANTIDEPRESSANTS

    May 1, 2020, 00:00

  • PMS23 RATE AND REIMBURSEMENT OF 1-LEVEL AND 2+-LEVEL REOPERATIONS IN CERVICAL TOTAL DISC REPLACEMENT AND ANTERIOR CERVICAL DISCECTOMY AND FUSION

    May 1, 2020, 00:00

  • Medical Devices - Economic Evaluation

    May 1, 2020, 00:00

  • Mental Health - Health Policy Regulatory

    May 1, 2020, 00:00

  • PCV66 GUIDELINE-DIRECTED MEDICAL THERAPY AMONG HEART FAILURE PATIENTS FACILITATED BY NATURAL LANGUAGE PROCESSING OF AMBULATORY ELECTRONIC HEALTH RECORDS

    May 1, 2020, 00:00

  • Biologics/Biosimilars/Regenerative Medicine - Health Service Delivery Process of Care

    May 1, 2020, 00:00

  • PIH50 FACTORS AND PATTERNS OF OFF-LABEL PRESCRIBING IN CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN US. OUTPATIENT SETTINGS OVER A TEN-YEAR PERIOD

    May 1, 2020, 00:00

  • PIH75 ASSESSMENT OF THE RATIONALITY OF PRESCRIBING IN ELDERLY INPATIENTS OF A SOUTH INDIAN HOSPITAL USING BEERS 2015 AND STOPP CRITERIA

    May 1, 2020, 00:00

  • PCV52 EFFECTIVENESS OF A CARDIOVASCULAR DISEASE PREVENTION PROGRAM IN THE CONTROL OF CARDIOVASCULAR RISK FACTORS IN A LOW-INCOME POPULATION FROM THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00

  • Multiple Diseases - Economic Evaluation

    May 1, 2020, 00:00

  • PMS49 EPIDEMIOLOGICAL DISEASE BURDEN OF SUBTROCHANTERIC FRACTURE BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00

  • PCV70 CLINICAL DECISION SUPPORT INTERVENTIONS FOR PROMOTING GUIDELINE-CONCORDANT ANTICOAGULATION IN PATIENTS WITH ATRIAL FIBRILLATION: TARGETED LITERATURE REVIEW OF KEY FEATURES AND GAPS IN EVIDENCE

    May 1, 2020, 00:00

  • PMU27 ASSESSING RELATIONSHIPS AMONG HOSPITALIZATIONS FOR SPINE-RELATED INFECTIONS, DEMOGRAPHICS, COSTS, AND COMORBIDITY DIAGNOSES IN THE UNITED STATES

    May 1, 2020, 00:00

  • PDG66 QUALITY OF LIFE AND ADHERENCE OF PATIENTS TO ORAL NEUROLOGY SPECIALTY MEDICATIONS PROVIDED BY A SPECIALTY PHARMACY

    May 1, 2020, 00:00

  • PMH72 HEALTHCARE RESOURCE UTILIZATION (HRU) ASSOCIATED WITH EXTENDED-RELEASE NALTREXONE (XR-NTX) COMPARED WITH OTHER TREATMENTS IN PUBLICLY INSURED PATIENTS WITH OPIOID USE DISORDER (OUD)

    May 1, 2020, 00:00

  • PMD3 ONE-YEAR COMPLICATIONS AND REIMBURSEMENT AFTER FIXATION WITH PLATING AND SCREWS FOR DISTAL FEMUR FRACTURES AMONG THE MEDICARE POPULATION

    May 1, 2020, 00:00

  • Alternative Medicine Process of Care

    May 1, 2020, 00:00

  • PMS94 PREDICTORS OF IMPROVEMENT IN TENDER JOINT COUNTS AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN A LARGE, REPRESENTATIVE US-BASED REAL WORLD REGISTRY COHORT

    May 1, 2020, 00:00

  • PMS67 DIFFERENCES IN HEALTHCARE EXPENDITURE BETWEEN OPIOID AND NON-OPIOID USERS AMONG A NATIONAL SAMPLE OF COMMUNITY-BASED OLDER UNITED STATES ADULTS WITH PAIN, 2015

    May 1, 2020, 00:00

  • PDB20 IS HYPOGLYCEMIA EXPENSIVE？

    May 1, 2020, 00:00

  • PMS56 EPIDEMIOLOGICAL DISEASE BURDEN OF FRACTURE OF SKULL AND FACIAL BONES BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00

  • PCV67 OPERATIONAL FEASIBILITY OF PHARMACIST GUIDED PERSONALIZED CONSULT SERVICE IN MANDATORY AND OPTIONAL SETTINGS

    May 1, 2020, 00:00

  • PMH27 ADHD TREATMENT AND DIAGNOSIS AMONG TEENAGE AND COLLEGE-AGED WOMEN

    May 1, 2020, 00:00

  • PIN88 THE EXAMINATION OF THE PARENTAL DECISION ON CHOOSING VARICELLA VACCINATION

    May 1, 2020, 00:00

  • Medical Devices - Methodological Statistical Research

    May 1, 2020, 00:00

  • PDG45 LOW-VALUE CARE: THE ASSOCIATION OF ANTIPSYCHOTIC POLYPHARMACY USE TO ECONOMIC BURDEN IN NON-INSTITUTIONALIZED CIVILIAN POPULATION IN THE UNITED STATES

    May 1, 2020, 00:00

  • PDB64 THERAPEUTIC INERTIA IN THE TREAMENT OF PATIENTS WITH TYPE 2 DIABETES IN A CARDIOVASCULAR RISK MANAGEMENT COHORT FROM THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00

  • PIT7 DOES INTRAARTICULAR INVOLVEMENT INCREASE THE RISK OF COMPLICATIONS AFTER FRACTURE REPAIR SURGERY?

    May 1, 2020, 00:00

  • Musculoskeletal Disorders - Medical Technologies

    May 1, 2020, 00:00

  • Individual's Health - Health Policy Regulatory

    May 1, 2020, 00:00

  • PIH64 ADJUSTED INDIRECT COMPARISON OF THE MEDICINES USING IN CONTROLLED OVARIAN STIMULATION FOR ASSISTED REPRODUCTIVE TECHNOLOGY

    May 1, 2020, 00:00

  • PMS16 ANNUAL HEALTH INSURANCE TREATMENT COST OF SCOLIOSIS BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00

  • PDB44 DOES INCLUDING ACUTE PANCREATITIS AS A COMPLICATION HAVE AN IMPACT ON COST-EFFECTIVENESS ANALYSES USING THE IQVIA CORE DIABETES MODEL?

    May 1, 2020, 00:00

  • Individual's Health - Economic Evaluation

    May 1, 2020, 00:00

  • PGI11 COMPARISON OF BURDEN OF HOSPITALIZATIONS IN INFLAMMATORY BOWEL DISEASE (IBD) WITH AND WITHOUT COLORECTAL CANCER: A PROPENSITY SCORE MATCHED ANALYSIS OF IN-PATIENT CLAIMS DATABASE

    May 1, 2020, 00:00

  • PMH51 WHAT ARE THE ATTRIBUTES THAT PSYCHIATRISTS CONSIDER IN THE DECISION TO DISCHARGE ADULTS WITH MAJOR DEPRESSIVE DISORDER WHO HAVE BEEN HOSPITALIZED WITH ACTIVE SUICIDAL IDEATION WITH INTENT?

    May 1, 2020, 00:00

  • Cancer - Clinical Outcomes

    May 1, 2020, 00:00

  • PMS83 PILOT INVESTIGATION OF THE QUALITY OF LIFE AND SOCIO-DEMOGRAPHIC FACTORS OF PATIENTS UNDERWENT TOTAL HIP ARTHROPLASTY IN THE STATE HEALTH CARE SECTOR IN HUNGARY

    May 1, 2020, 00:00

  • PCV62 ASSOCIATED FACTORS TO THE CONTROL OF CARDIOVASCULAR RISK IN A LOW-INCOME POPULATION FROM THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00

  • PGI17 COST EFFECTIVENESS ANALYSIS OF ENDOSCOPIC CAPSULE FOR DIAGNOSIS OF OBSCURE GASTROINTESTINAL BLEEDING IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    May 1, 2020, 00:00

  • PIH25 PRE-TERM LABOR TRANSPORT: UTILIZATION PATTERNS AND COST AMONG WOMEN IN RURAL AND NON-RURAL AREAS

    May 1, 2020, 00:00

  • Medical Devices - Health Technology Assessment

    May 1, 2020, 00:00

  • PIH40 INCIDENCE AND BURDEN OF RECURRENT VAGINITIS AMONG COMMERCIALLY INSURED WOMEN IN THE US

    May 1, 2020, 00:00

  • PCV87 HEART FAILURE RISK FACTORS ANALYSIS ON STABLE CORONARY ARTERY DISEASE PATIENTS IN CHINA

    May 1, 2020, 00:00

  • PIN72 NON-PRESCRIPTION SALES OF ANTIMICROBIALS FROM COMMUNITY PHARMACIES AND DETERMINANTS OF RESISTANCE IN LAHORE PAKISTAN

    May 1, 2020, 00:00

  • PDB54 EVALUATING THE IMPACT OF POOR GLYCEMIC CONTROL ASSOCIATED WITH THERAPEUTIC INERTIA ON LIFE EXPECTANCY IN PATIENTS WITH TYPE 2 DIABETES IN THE UK

    May 1, 2020, 00:00

  • PMS4 OUTPATIENT COSTS IN RHEUMATOID ARTHRITIS (RA) PATIENTS WITH VS WITHOUT COMORBIDITIES

    May 1, 2020, 00:00

  • PMS12 HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH GIANT CELL ARTERITIS IN THE UNITED STATES

    May 1, 2020, 00:00

  • PDG13 CURRENT PRESCRIPTION PROFILE OF RIBAVIRIN FOR HEPATITIS C IN BRAZIL AND THE BUDGET IMPACT ANALYSIS ON UPDATED RECOMMENDATIONS FOR ITS USE BETWEEN 2020 AND 2024 IN THE BRAZILIAN PUBLIC HEALTH SYSTEM

    May 1, 2020, 00:00

  • PBI35 HEALTH TECHNOLOGY ASSESSMENT (HTA) REVIEW OF CELL GENE THERAPIES: THE ROAD TO REIMBURSEMENT

    May 1, 2020, 00:00

  • PMH66 THE BURDEN OF COST TO PATIENTS WITH OPIOID USE DISORDER TREATED WITH MEDICATION ASSISTED THERAPY: A SYSTEMATIC SCOPING REVIEW

    May 1, 2020, 00:00

  • PDG38 ASSESSMENT OF GENERIC COMPETITION FOR ORPHAN DRUGS MARKETED IN THE US (1993-2019)

    May 1, 2020, 00:00

  • PCN16 RESECTION FOR RECURRENT BRAIN METASTASES: A SYSTEMATIC REVIEW AND META-ANALYSIS

    May 1, 2020, 00:00

  • PMS42 HEALTHCARE EXPENDITURE HEALTH-RELATED QUALITY OF LIFE OF MUSCULOSKELETAL PAIN PATIENTS ON OPIOIDS VERSUS NSAIDS

    May 1, 2020, 00:00

  • PDB48 THE COMPARISON OF SGLT2 INHIBITORS AND DPP-4 INHIBITORS ON HEALTH CARE EXPENDITURE AND UTILIZATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

    May 1, 2020, 00:00

  • PDB57 VALIDATION OF UKPDS OUTCOMES AND TAIWAN DIABETES MODELS ON TAIWAN TYPE 2 DM POPULATION

    May 1, 2020, 00:00

  • Insights From a Temporal Assessment of Increases in US Private Payer Coverage of Tumor Sequencing From 2015 to 2019

    May 1, 2020, 00:00

  • PCN7 COMPARATIVE EFFECTIVENESS OF GRANULOCYTE COLONY STIMULATING FACTOR UTILIZATION VERSUS CHEMOTHERAPY DOSE REDUCTION ON OVERALL SURVIVAL: A PROPENSITY SCORE MATCHED ANALYSIS

    May 1, 2020, 00:00

  • PBI7 BUDGET IMPACT ANALYSIS OF INTRODUCTION OF BEVACIZUMAB BIOSIMILAR IN THE UNITED STATES FROM A PAYER PERSPECTIVE

    May 1, 2020, 00:00

  • Biologics/Biosimilars/Regenerative Medicine - Clinical Outcomes

    May 1, 2020, 00:00

  • PIN89 REGIMEN DURABILITY AMONG HEAVILY TREATMENT-EXPERIENCED (HTE) COMPARED TO NON-HTE TREATMENT-EXPERIENCED HIV PATIENTS IN THE OPERA COHORT

    May 1, 2020, 00:00

  • PDB39 COST-EFFECTIVENESS OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN ARGENTINA

    May 1, 2020, 00:00

  • PMH37 FACTORS INFLUENCING THE UPTAKE OF MENTAL HEALTH SERVICES IN SUB-SAHARAN AFRICA.

    May 1, 2020, 00:00

  • PIH8 UNDERSTANDING THE ECONOMIC BURDEN OF COMORBIDITIES ASSOCIATED WITH MALE HYPOGONADISM: A COST MODEL IN ENGLAND

    May 1, 2020, 00:00

  • PGI4 RETROSPECTIVE STUDY OF DOSE ESCALATION WITH ADALIMUMAB, INFLIXIMAB, AND VEDOLIZUMAB IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

    May 1, 2020, 00:00

  • PBI3 TRANSFUSION-RELATED ABO INCOMPATIBILITY REACTIONS AMONG THE INPATIENT U.S. MEDICARE BENEFICIARIES, AGES 65 AND OLDER, DURING 2007-2018

    May 1, 2020, 00:00

  • PMU32 A DEVICE CATEGORY-BASED ECONOMIC MODEL EXPLORING ELECTROSURGERY TECHNOLOGIES ACROSS PROCEDURE TYPES: A CHINESE ANALYSIS

    May 1, 2020, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Epidemiology Public Health

    May 1, 2020, 00:00

  • PIN55 ASSOCIATION OF GEOGRAPHIC FACTORS AND SOCIAL DETERMINANTS WITH HERPES ZOSTER VACCINATION

    May 1, 2020, 00:00

  • PDB10 EVALUATION OF THE RATE OF PREVENTABLE DIABETES-RELATED HOSPITALIZATIONS IN MEDICAID

    May 1, 2020, 00:00

  • Multiple Diseases - Clinical Outcomes

    May 1, 2020, 00:00

  • Cardiovascular Disorders - Patient-Centered Research

    May 1, 2020, 00:00

  • PDB21 EVALUATION OF THE ONE-YEAR EFFICIENCY OF THE EDUC@DOM TELEMONITORING AND TELE-EDUCATION PROGRAM FOR TYPE 2 DIABETIC PATIENTS

    May 1, 2020, 00:00

  • PMD31 IS A SUPERFICIAL INFECTION AN INDEPENDENT PREDICTOR FOR A LATER DEEP INCISIONAL INFECTION IN TOTAL KNEE ARTHROPLASTY?

    May 1, 2020, 00:00

  • PDG26 THE ASSOCIATION OF BETA-BLOCKERS USE TO CHRONIC PAIN AMONG ADULTS WITH CARDIOVASCULAR DISEASES (CVD) OR HYPERTENSION IN THE UNITED STATES

    May 1, 2020, 00:00

  • Comparative Effectiveness Studies Methods

    May 1, 2020, 00:00

  • PMS81 PRESCRIPTION DRUG COVERAGE TYPE, OUT-OF-POCKET SPENDING, AND COST-RELATED NONADHERENCE AMONG MEDICARE BENEFICIARIES WITH RHEUMATOID ARTHRITIS

    May 1, 2020, 00:00

  • Musculoskeletal Disorders - Epidemiology Public Health

    May 1, 2020, 00:00

  • PB3 DISCORDANCE BETWEEN PSYCHIATRISTS AND THEIR PATIENTS ON DISEASE SEVERITY AND TREATMENT OUTCOMES IN SCHIZOPHRENIA

    May 1, 2020, 00:00

  • PGI13 A BUDGET IMPACT ANALYSIS OF FIDAXOMICIN FOR THE MANAGEMENT OF CLOSTRIDIOIDES DIFFICILE INFECTION IN THE UNITED STATES

    May 1, 2020, 00:00

  • Mental Health - Health Technology Assessment

    May 1, 2020, 00:00

  • PBI34 IMPACTS OF LONG-TERM UNCERTAINTY AND FAMILY SPILLOVER EFFECTS ON THE COST-UTILITY OF APPROVED TREATMENTS FOR SMA TYPE I

    May 1, 2020, 00:00

  • PCV79 GENDER DISPARITY IN THE INITIATION AND COMPLIANCE FOR STATIN THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE (CAD)

    May 1, 2020, 00:00

  • PDG24 OPIOID-RELATED OVERDOSE IN PATIENTS WITH CONCURRENT USE OF OPIOIDS AND BENZODIAZEPINES: A NESTED CASE-CONTROL STUDY OF COMMERCIALLY INSURED PATIENTS

    May 1, 2020, 00:00

  • PMS20 COST EFFECTIVENESS OF VIRTUAL REALITY GAME VERSUS CLINIC BASED MCKENZIE EXTENSION THERAPY FOR CHRONIC NON SPECIFIC LOW BACK PAIN

    May 1, 2020, 00:00

  • PDG67 PREDICTORS OF CHRONIC MEDICATION NONADHERENCE IN CANCER SURVIVORS: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00

  • PMD17 ANALYSIS OF THE COST-EFFECTIVENESS OF ENDOVASCULAR AORTIC REPAIR WITH OFF-THE-SHELF ENDOGRAFTS AS ALTERNATIVE TO CUSTOM-MADE ENDOGRAFTS IN PRIVATE HEALTH INSURANCE IN BRAZIL

    May 1, 2020, 00:00

  • PMS79 PHASE 1B EVALUATION OF PATIENT EXPERIENCE WITH ABALOPARATIDE SOLID MICROSTRUCTURED TRANSDERMAL SYSTEM IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY

    May 1, 2020, 00:00

  • PGI26 THE COST-EFFECTIVENESS OF PHARMACOLOGIC VS SURGICAL INTERVENTION FOR PATIENTS HOSPITALIZED WITH ACUTE SEVERE ULCERATIVE COLITIS IN THE UNITED STATES

    May 1, 2020, 00:00

  • Alternative Medicine Nutrition - Clinical Outcomes

    May 1, 2020, 00:00

  • PMH15 THE CHANGES OF DEPRESSION COSTS AFTER AN INTERNET-DELIVERED COGNITIVE BEHAVIOUR THERAPIES (IDCBT) PRELIMINARY DATA FROM RWD ECONOMIC MODEL

    May 1, 2020, 00:00

  • PDB40 COST-EFFECTIVENESS ANALYSIS OF SENSOR-AUGMENTED PUMP IN TYPE 1 DIABETES MELLITUS COMPARED WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN THE RUSSIAN FEDERATION

    May 1, 2020, 00:00

  • PIN21 ESTABLISH A PHARMACEUTICAL CARE MODE FOR THERAPEUTIC DRUG MONITORING OF VANCOMYCIN AND EVALUATE ITS EFFECTIVENESS AND ECONOMICS

    May 1, 2020, 00:00

  • PDB12 EFFICACY AND SAFETY OF ETELCALCETIDE IN THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN ADULT PATIENTS WITH CHRONIC KIDNEY DISEASE UNDERGOING DIALYSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS

    May 1, 2020, 00:00

  • Alternative Medicine Information Systems

    May 1, 2020, 00:00

  • PMU5 PREVALENCE AND ASSOCIATED FACTORS TO PSYCHOTIC SUBSTANCE USE IN LOW-INCOME ADOLESCENTS FROM THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00

  • PMH11 LONG-TERM MEDICATION-ASSISTED TREATMENT OF OPIOID USE DISORDER IN THE UNITED STATES: A COST-UTILITY ANALYSIS

    May 1, 2020, 00:00

  • PDB59 THE IMPACT OF HYPERKALAEMIA AND ITS CONCURRENCE WITH CARDIORENAL COMORBIDITIES ON HEALTHCARE RESOURCE USE IN THE UK

    May 1, 2020, 00:00

  • PDG9 PREVALENCE OF POLYMEDICATION IN POOR POPULATION OF THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00

  • PMS45 CLINICAL CHARACTERISTICS AND HEALTH OUTCOMES IN A GROUP OF ELDERLY PATIENTS WITH HIP FRACTURE IN MANIZALES, COLOMBIA.

    May 1, 2020, 00:00

  • PGI35 REAL-WORLD MEDICATION USE AND COST OF ILLNESS IN IRRITABLE BOWEL SYNDROME WITH CONSTIPATION IN THE CHINESE SETTING

    May 1, 2020, 00:00

  • PDB35 A COST MINIMIZATION ANALYSIS OF NEGATIVE PRESSURE WOUND THERAPY TECHNOLOGIES FOR THE TREATMENT OF MODERATE TO SEVERE FOOT INFECTIONS

    May 1, 2020, 00:00

  • PIH67 EVALUATING THE BURDEN OF ILLNESS OF PEDIATRIC PLATINUM-INDUCED HEARING LOSS: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00

  • PMD10 A BUDGET IMPACT AND RETURN ON INVESTMENT ANALYSIS OF INCORPORATING DRUG – ELUTING STENTS INTO A CHINESE HOSPITAL MEDICAL DEVICE FORMULARY — A HOSPITAL PERSPECTIVE

    May 1, 2020, 00:00

  • PIN69 NOW OR LATER: THE COST BURDEN OF HCV INFECTION VS. TREATMENT FOR MEDICARE AND MEDICAID POPULATIONS

    May 1, 2020, 00:00

  • PIH18 POLYPHARMACY, HEALTHCARE EXPENDITURES AND HEALTH STATUS AMONG OLDER ADULTS WITH CARDIAC DISEASE

    May 1, 2020, 00:00

  • PDG17 COST-EFFECTIVENESS ANALYSIS OF ARSENIC TRIOXYDE FOR FIRST LINE TREATMENT OF ACUTE PROMYELOCTIC LEUKEMIA

    May 1, 2020, 00:00

  • Mental Health - Real World Data Information Systems

    May 1, 2020, 00:00

  • PMU6 EFFECTIVENESS OF A NATIVE TYPE I COLLAGEN MATRIX PLUS POLYHEXAMETHYLENE BIGUANIDE ANTIMICROBIAL (PHMB) FOR THE TREATMENT OF CUTANEOUS WOUNDS IN A REAL WORLD SETTING

    May 1, 2020, 00:00

  • PMD25 EVALUATING BUDGET IMPACT OF PERIPROSTHETIC JOINT INFECTION DIAGNOSIS PATHWAYS IN TOTAL HIP AND KNEE ARTHROPLASTY PATIENTS

    May 1, 2020, 00:00

  • PCV89 ASSESSMENT OF CARE OPPORTUNITY GAPS FOR ATRIAL FIBRILLATION IN NHS ENGLAND

    May 1, 2020, 00:00

  • PIH15 ANNUAL HEALTH INSURANCE TREATMENT COST OF ENDOMETRIOSIS BASED ON ROUTINELY COLLECTED FINANCING DATA

    May 1, 2020, 00:00

  • Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing–Based Tests: Challenges, Opportunities, and Potential Solutions

    May 1, 2020, 00:00

  • PMU14 THE USE OF PERSPECTIVE AND COSTING APPROACHES IN COST-EFFECTIVENESS ANALYSIS

    May 1, 2020, 00:00

  • PMU33 THE IMPACT OF HIGH RISK AND CHRONIC OPOID USE AMONG COMMERCIALLY INSURED ENDOMETRIOSIS PATIENTS ON HEALTHCARE RESOURCE USE AND COSTS IN THE UNITED STATES

    May 1, 2020, 00:00

  • PIN59 17-YEAR DISEASE REDUCTION PREDICTED BY A TRANSMISSION DYNAMIC MODEL AFTER PNEUMOCOCCAL CONJUGATE VACCINE INTRODUCTION IN THE UNITED STATES

    May 1, 2020, 00:00

  • PMU44 PREVALENCE OF MULTIMORBIDITY AMONG ASIAN INDIANS, CHINESE, AND NON-HISPANIC WHITES IN THE UNITED STATES

    May 1, 2020, 00:00

  • PIN38 COST-EFFECTIVENESS OF TESAMORELIN IN THE TREATMENT OF LIPOHYPERTROPHY IN THE US

    May 1, 2020, 00:00

  • PIN4 IMPACT OF ADHERENCE ON VIRAL SUPPRESSION IN PATIENTS WITH HIV RECEIVING BICTEGRAVIR OR DOLUTEGRAVIR REGIMENS

    May 1, 2020, 00:00

  • PDG44 COPRESCRIBING OF OPIOIDS AND BENZODIAZEPINES IN TEXAS MEDICAID ENROLLEES

    May 1, 2020, 00:00

  • PBI32 EVOLUTION OF THE COST OF MEDICINES ACQUIRED BY THE COSTA RICAN SOCIAL SECURITY SYSTEM (CCSS) ACCORDINGLY TO ITS ORIGIN: BIOLOGICAL OR CHEMICAL SYNTHESIS

    May 1, 2020, 00:00

  • PGI30 WEB-BASED RESEARCH OF QUALITY OF LIFE OUTCOME AND STATUS OF MEDICAL EXPENSE SUBSIDY FOR INTRACTABLE DISEASE FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN JAPAN

    May 1, 2020, 00:00

  • PBI23 DEPRESSION AND OBESITY DIFFERENCES AMONG PSORIASIS PATIENTS BY BIOLOGICS TREATMENT

    May 1, 2020, 00:00

  • Defining Comparators According to IQWiG’s Efficiency-Frontier Method

    May 1, 2020, 00:00

  • Alternative Medicine Nutrition - Medical Technologies

    May 1, 2020, 00:00

  • PDG52 CONCOMITANT USE OF OPIOIDS AND CENTRAL NERVOUS SYSTEM DEPRESSANTS IN PATIENTS WITH NONMALIGNANT CHRONIC PAIN AND ADHERENCE TO FOOD AND DRUG ADMINISTRATION WARNING

    May 1, 2020, 00:00

  • PDB92 GETTING THE MOST OUT OF LATENT-CLASS ANALYSIS IN MODELING PREFERENCES FOR AN INTERCEPTION TREATMENT IN TYPE 1 DIABETES

    May 1, 2020, 00:00

  • PMS89 A REAL-WORLD STUDY OF THE PATIENT EXPERIENCE WITH ABALOPARATIDE

    May 1, 2020, 00:00

  • Drugs Generics - Organizational Practices

    May 1, 2020, 00:00

  • PCV88 THE APPLICATION OF BAYESIAN HETEROGENEITY TREATMENT EFFECT ANALYSIS FOR ASSESSING VARIATION AND RELIABILITY OF CONGESTIVE HEART FAILURE OUTCOMES IN A LINKED EMR-CLAIMS DATASET

    May 1, 2020, 00:00

  • PDB23 EXLORATION IN HEALTHCARE RESOURCE UTILIZATION (HCRU) STUDY USING EMR DATABASE AND CLAIMS DATA

    May 1, 2020, 00:00

  • PCN14 UPDATED NETWORK META-ANALYSIS OF FIRST-LINE EGFR-TARGETED TYROSINE KINASE INHIBITOR TREATMENTS FOR LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER WITH EGFR-ACTIVATING MUTATIONS

    May 1, 2020, 00:00

  • Individual's Health - Patient-Centered Research

    May 1, 2020, 00:00

  • Cardiovascular Disorders - Health Technology Assessment

    May 1, 2020, 00:00

  • PDG6 HEALTH JUDICIALIZATION IN BRAZIL: IMPACT OF MIGLUSTATE MEDICINE OBLIGATION FOR PATIENTS WITHOUT OFFICIAL INDICATION OF USE, IN 2019 IN BRAZIL

    May 1, 2020, 00:00

  • PDG33 CHANGES IN SCHEDULE II ORAL OPIOID VOLUME DISPENSED IN A PRIVATE PAYER FOLLOWING FLORIDA’S ACUTE PAIN OPIOID RESTRICTION LAW

    May 1, 2020, 00:00

  • PDG49 DETERMINANTS OF NON-PHARMACOLOGIC THERAPY, OPIOID, NON-OPIOID/OPIOID COMBINATION, AND NON-OPIOID MEDICATIONS IN OUTPATIENTS WITH NONMALIGNANT CHRONIC PAIN USING RECENT NATIONAL SURVEY

    May 1, 2020, 00:00

  • PDB111 A COMPARATIVE EFFECTIVENESS RESEARCH STUDY OF A NATIVE TYPE I COLLAGEN MATRIX PLUS POLYHEXAMETHYLENE BIGUANIDE ANTIMICROBIAL AND A CRYOPRESERVED CADAVERIC SKIN ALLOGRAFT FOR USE IN DIABETIC FOOT ULCERS - A NON-INFERIORITY ANALYSIS

    May 1, 2020, 00:00

  • PGI20 THE IMPACT OF ULCERATIVE COLITIS ON WORK PRODUCTIVITY: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00

  • PMS19 A SYSTEMATIC REVIEW OF ECONOMIC MODELS FOR COST EFFECTIVENESS OF PHYSIOTHERAPY INTERVENTION FOLLOWING TOTAL KNEE AND HIP REPLACEMENT

    May 1, 2020, 00:00

  • Patient Behavior Studies

    May 1, 2020, 00:00

  • Injury Public Health

    May 1, 2020, 00:00

  • PMU19 FIRST LINE TREATMENT WITH NATALIZUMAB REDUCES HEALTHCARE RESOURCE USE AND IMPAIRMENT OF WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) PATIENTS COMPARED TO NATALIZUMAB DELAYED USE

    May 1, 2020, 00:00

  • PCV86 EXAMINING PREDICTORS OF DURATION OF INITIAL ANTIHYPERTENSIVE THERAPY

    May 1, 2020, 00:00

  • Multiple Diseases - Epidemiology Public Health

    May 1, 2020, 00:00

  • PMS30 ANNUAL HEALTH INSURANCE TREATMENT COST OF SUBTROCHANTERIC FRACTURE BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00

  • PCN2 PROJECTED LIFETIME CLINICAL VALUE OF A MULTICANCER EARLY DETECTION TEST

    May 1, 2020, 00:00

  • Alternative Medicine Statistical Research

    May 1, 2020, 00:00

  • Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the ISPOR Personalized Precision Medicine Special Interest Group [Editor's Choice]

    May 1, 2020, 00:00

  • PMU15 RETROSPECTIVE STUDY EXAMINING HEALTH CARE UTILIZATION AND COSTS FOR PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS IN THE US

    May 1, 2020, 00:00

  • PIT4 ECONOMIC BURDEN OF HOSPITALIZATIONS RELATED TO MAJOR AND MEDIUM BURN INJURIES IN BRAZIL

    May 1, 2020, 00:00

  • PMD22 BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF MECHANICAL THROMBECTOMY WITH STENT RETRIEVERS AFTER THROMBOLYSIS IN ISCHEMIC-STROKE WITH LARGE VESSEL OCCLUSION IN THE CHILEAN PUBLIC SECTOR.

    May 1, 2020, 00:00

  • PMU59 GLOBAL OUTCOMES-BASED CONTRACTING TRENDS IN THE US AND EUROPE OVER THE PAST 5 YEARS

    May 1, 2020, 00:00

  • PBI42 DISCONTINUATION PLAYS A ROLE WHEN EVALUATING THE COST EFFECTIVENESS OF THE SECOND BIOLOGICAL DRUG FOR PATIENTS WITH RHEUMATOID ARTHRITIS

    May 1, 2020, 00:00

  • PMH10 DETERMINANTS, TRENDS, AND COSTS ASSOCIATED WITH 30-DAY ALL-CAUSE READMISSION IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH SUICIDAL IDEATION USING THE NATIONWIDE READMISSION DATABASE

    May 1, 2020, 00:00

  • Gastrointestinal Disorders - Economic Evaluation

    May 1, 2020, 00:00

  • PIH70 FORMATIVE RESEARCH TO DEVELOP A CLINICAL TRIAL DECISION AID THAT INTEGRATES QUANTITATIVE PATIENT PREFERENCE DATA

    May 1, 2020, 00:00

  • PIN79 VACCINATION COVERAGE RATE: WHAT CAN WE EXPECT FROM BRAZIL?

    May 1, 2020, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Patient-Centered Research

    May 1, 2020, 00:00

  • PIN13 ESTIMATING THE IMPACT OF A GENDER-NEUTRAL QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM IN ALL HPV 6/11/16/18 -RELATED DISEASES IN COLOMBIA

    May 1, 2020, 00:00

  • PDB50 ANNUAL HEALTH INSURANCE TREATMENT COST OF DIABETIC POLYNEUROPATHY BASED ON ROUTINELY COLLECTED FINANCING DATA

    May 1, 2020, 00:00

  • PAM2 ORAL NUTRITIONAL SUPPLEMENTATION CAN IMPROVE POSTOPERATIVE OUTCOMES FOR COLORECTAL SURGERY PATIENTS

    May 1, 2020, 00:00

  • PIN76 CHARACTERISTICS OF PATIENTS WITH CHRONIC HEPATITIS C TREATED UNDER A NEW STANDARD OF CARE

    May 1, 2020, 00:00

  • PIN15 BUDGETARY IMPACT ANALYSIS OF SHORTENING TREATMENT FOR MULTIDRUG-RESISTANT TUBERCULOSIS IN BRAZIL

    May 1, 2020, 00:00

  • PMD23 ANALYSIS OF THE COST-EFFECTIVENESS OF TRANSCATHETER AORTIC VALVE REPLACEMENT AS ALTERNATIVE TO SURGICAL AORTIC VALVE REPLACEMENT IN PRIVATE HEALTH INSURANCE IN BRAZIL

    May 1, 2020, 00:00

  • PCV65 HOSPITALIZATIONS AND MORTALITY AMONG CARDIAC AMYLOIDOSIS PATIENTS COVERED BY MEDICARE ADVANTAGE

    May 1, 2020, 00:00

  • PMH40 TRENDS IN ATYPICAL ANTIPSYCHOTIC MEDICATION USE IN US ADULTS

    May 1, 2020, 00:00

  • PDG32 GAME-THEORETICAL ANALYSIS OF NETFLIX PAYMENT MODEL FOR HEPATITIS C TREATMENT

    May 1, 2020, 00:00

  • PIN62 PREVALENCE AND FACTORS ASSOCIATED WITH NEVER-VACCINATED CHILDREN AGED 12-59 MONTHS IN ETHIOPIA. A MULTILEVEL ANALYSIS OF THE INDIVIDUAL AND CONTEXTUAL FACTORS

    May 1, 2020, 00:00

  • PDB83 THE ROLE OF HEALTH CARE PROVIDER'S ADVICE IN PREDIABETES MANAGEMENT IN THE US

    May 1, 2020, 00:00

  • PCV78 ASSESSMENT OF HEALTH LITERACY AND THERAPEUTIC ADHERENCE AMONG PATIENTS WITH HYPERTENSION

    May 1, 2020, 00:00

  • PIN6 CLINICAL BENEFITS AND COST SAVINGS FROM IMPLEMENTING A SIMPLIFIED STRATEGY FOR GLECAPREVIR/PIBRENTASVIR (G/P) 8-WEEK TREATMENT IN NON-CIRRHOTIC NAÃVE PATIENTS WITH HEPATITIS C. THE JUST SIMPLE STUDY (REAL CLINICAL PRACTICE IN SPAIN).

    May 1, 2020, 00:00

  • PIH38 MEASURING A RISK OF AND FACTORS ASSOCIATED WITH IN-HOME TOBACCO SMOKE EXPOSURE IN A US PEDIATRIC SAMPLE: HOUSEHOLD ECONOMICS AND VOLATILE ORGANIC COMPOUND METABOLITE DETECTION

    May 1, 2020, 00:00

  • PMS21 ANNUAL HEALTH INSURANCE TREATMENT COST OF INJURIES TO THE ELBOW AND FOREARM BASED ON ROUTINELY COLLECTED REAL-WORLD FINANCING DATA

    May 1, 2020, 00:00

  • PCV60 PREVALENCE, RISK FACTORS, AND MANAGEMENT OF UNCONTROLLED HYPERTENSION AMONG DIABETIC PATIENTS: A HOSPITAL-BASED CROSS-SECTIONAL STUDY

    May 1, 2020, 00:00

  • Musculoskeletal Disorders - Health Technology Assessment

    May 1, 2020, 00:00

  • PIH76 ITCH REPORTED OUTCOME TOOL FOR CAREGIVERS OF PEDIATRIC PATIENTS WITH CHOLESTATIC LIVER DISEASE: AN ANALYSIS OF VALIDATION AND SCORING FROM THE ICONIC MARALIXIBAT STUDY

    May 1, 2020, 00:00

  • PMH31 RISK OF FALLS AND FRACTURES ASSOCIATED WITH CONCOMITANT USE OF ACETYLCHOLINESTERASE INHIBITORS AND ATYPICAL ANTIPSYCHOTICS AMONG OLDER ADULTS WITH DEMENTIA

    May 1, 2020, 00:00

  • PCV75 IDENTIFYING APPROPIATE HOSPITALS FOR PATIENT RECRUITMENT IN CLINICAL TRIALS FOR CANADA USING MACHINE LEARNING ALGORITHMS

    May 1, 2020, 00:00

  • PMU58 SMART SPENDING: REALLOCATING AMERICANS’ FOOD BUDGETS TO SAVE COSTS AND IMPROVE DIET QUALITY

    May 1, 2020, 00:00

  • PDB28 QUALITY ADJUSTED LIFE YEARS (QALYS) IN THE DIABETES PREVENTION PROGRAM (DPP) USING QUALITY OF WELL BEING (QWB) AND SF-6D INSTRUMENTS IN SAME SAMPLE: COMPLETE CASE ANALYSIS

    May 1, 2020, 00:00

  • Injury Information Systems

    May 1, 2020, 00:00

  • PIH37 INEQUALITY OF OPPORTUNITY IN MATERNAL HEALTH AMONG ADOLESCENTS

    May 1, 2020, 00:00

  • PMS55 EPIDEMIOLOGICAL DISEASE BURDEN OF INJURIES TO THE KNEE AND LOWER LEG BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00

  • PIN9 ADHERENCE ISSUES AMONG PEOPLE LIVING WITH HIV ON ANTIRETROVIRAL THERAPY AND CONCOMITANT NON-ANTIRETROVIRAL COMEDICATIONS: A SYSTEMATIC REVIEW

    May 1, 2020, 00:00

  • PMS51 GABAPENTIN, OPIOID, AND BENZODIAZEPINE PRESCRIBING IN EARLY CARE OF INDIVIDUALS WITH CHRONIC BACK PAIN: A SECULAR TRENDS ANALYSIS

    May 1, 2020, 00:00

  • PIH7 ANNUAL HEALTH INSURANCE TREATMENT COST OF CERVICAL CANCER BASED ON ROUTINELY COLLECTED NATIONWIDE REAL-WORLD FINANCING DATA IN HUNGARY

    May 1, 2020, 00:00

  • PIN51 FACTORS ASSOCIATED WITH INCREASED RISK OF HERPES ZOSTER AMONG PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    May 1, 2020, 00:00

  • PIN12 THE COST-EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN CHINESE CITIES

    May 1, 2020, 00:00

  • AI4 CAN WE DECREASE THE SCREENING BURDEN IN SYSTEMATIC REVIEWS? PERFORMANCE OF TWO NATURAL LANGUAGE PROCESSORS TO EXCLUDE RECORDS

    May 1, 2020, 00:00

  • Competing Views on the English EQ-5D-5L Valuation Set [Editor's Choice]

    May 1, 2020, 00:00

  • PDB14 HYPOTHERMICALLY STORED HUMAN AMNIOTIC MEMBRANE (HSAM) FOR THE MANAGEMENT OF DIABETIC FOOT ULCERS

    May 1, 2020, 00:00

  • PMH17 ECONOMIC BURDEN OF MEDICAID BENEFICIARIES WITH SCHIZOPHRENIA NOT ADHERENT TO ANTIPSYCHOTICS AND WITH SCHIZOPHRENIA RELAPSES

    May 1, 2020, 00:00

  • PCN4 ACCURACY OF LIFE YEAR GAIN PREDICTIONS FOR NIVOLUMAB MONOTHERAPY IN THE LONG TERM: AN ANALYSIS ACROSS FOUR INDICATIONS

    May 1, 2020, 00:00

  • PIN87 PATIENT ENGAGEMENT IN HIV CARE MANAGEMENT: BEHAVIOR ECONOMICS OF ART ADHERENCE AND ESTABLISHING CARE VISITS

    May 1, 2020, 00:00

  • PIN5 PREVALENCE OF DRUG RESISTANCE IN NUCLEOSIDE/NUCLEOTIDE ANALOGUE-TREATED EGYPTIAN PATIENTS WITH CHRONIC HEPATITIS B VIRUS

    May 1, 2020, 00:00

  • PMD46 RETROSPECTIVE ANALYSIS OF OXIDIZED ZIRCONIUM BEARING SURFACE AND MORTALITY IN HIP AND KNEE REPLACEMENT 180-DAY EPISODE CLAIMS

    May 1, 2020, 00:00

  • PDB73 EPIDEMIOLOGICAL DISEASE BURDEN OF DIABETIC POLYNEUROPATHY BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00

  • PCV57 THE BURDEN OF HEART FAILURE IN NORTH AMERICA AND WESTERN EUROPE

    May 1, 2020, 00:00

  • PDG50 COMMUNICATION BETWEEN PATIENTS AND HEALTH CARE PROFESSIONALS ABOUT OPIOID MEDICATIONS: A SYSTEMATIC REVIEW

    May 1, 2020, 00:00

  • PMU46 PSYCHOTROPIC POLYPHARMACY AMONG CHILDREN, ADOLESCENTS, AND YOUNG ADULTS TREATED WITH ANTIDEPRESSANTS IN THE UNITED STATES

    May 1, 2020, 00:00

  • PDG46 OUTPATIENT OFF-LABEL GABAPENTIN UTILIZATION FROM 2011 TO 2015 AMONG UNITED STATES ADULTS

    May 1, 2020, 00:00

  • Infectious Diseases - Real World Data Information Systems

    May 1, 2020, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Economic Evaluation

    May 1, 2020, 00:00

  • PIH48 DIFFERENTIAL PRESCRIPTION PATTERNS OF DROSPIRENONE-CONTAINING COMBINED ORAL CONTRACEPTIVES IN EUROPE AND NORTH AMERICA - INSIGHTS FROM THE INAS-FOCUS STUDY

    May 1, 2020, 00:00

  • PIH71 RISK FACTORS ASSOCIATED WITH FALLS AMONG THE ELDERLY IN U.S.: AN ANALYSIS OF MEDICARE CURRENT BENEFICIARY SURVEY DATA

    May 1, 2020, 00:00

  • PIH43 SEXUAL BEHAVIOR, USE OF CONTRACEPTIVE METHODS AND PREGNANCY IN YOUNG PEOPLE FROM A POPULATION AFFILIATED IN A HEALTH INSURER COMPANY IN COLOMBIA 2018

    May 1, 2020, 00:00

  • PMH24 BUDGET IMPACT ANALYSIS OF VORTIOXETINE AND/OR SERTRALINE USE FOR MANAGEMENT OF MAJOR DEPRESSIVE DISORDER IN THE KINGDOM OF SAUDI ARABIA

    May 1, 2020, 00:00

  • PMS82 PHYSICAL PARAMETERS AND THE FUNCTIONAL STATE OF THE SPINE IN AMATEUR TENNIS PLAYERS

    May 1, 2020, 00:00

  • PMS61 DISABILITY AND DEPRESSION IN LOW BACK PAIN. EVIDENCE FROM A COHORT STUDY

    May 1, 2020, 00:00

  • PMH63 HUMANISTIC BURDEN ASSOCIATED WITH MAJOR DEPRESSIVE DISORDER AND GLOBAL ANXIETY DISORDER AMONG ADULTS WITH NON-COMMUNICABLE DISEASES (NCCDS) IN THE UNITED STATES

    May 1, 2020, 00:00

  • Mental Health - Health Service Delivery Process of Care

    May 1, 2020, 00:00

  • The EQ-5D-5L Value Set for England: Response to the “Quality Assurance”

    May 1, 2020, 00:00

  • PDB26 ESTIMATED RENAL AND CARDIOVASCULAR OUTCOMES AND COST OFFSETS IN PATIENTS WITH TYPE 2 DIABETES (T2D) AND DIABETIC NEPHROPATHY (DKD) TREATED WITH CANAGLIFLOZIN

    May 1, 2020, 00:00

  • PDG75 PREVALENCE AND FACTORS ASSOCIATED WITH ANTIEPILEPTIC DRUG USE IN NURSING HOME RESIDENTS WITH PAIN

    May 1, 2020, 00:00

  • PIH45 COST-EFFECTIVENESS OF A CARE PUBLIC PROGRAM FOR PREGNANT WOMEN WHO HAD THEIR DELIVERY IN A THIRD - LEVEL - COMPLEXITY HOSPITAL AT COLOMBIA

    May 1, 2020, 00:00

  • PDB55 ANNUAL HEALTH INSURANCE TREATMENT COST OF NON-INSULIN-DEPENDENT DIABETES WITH MULTIPLE COMPLICATIONS BASED ON ROUTINELY COLLECTED FINANCING DATA

    May 1, 2020, 00:00

  • Medical Devices - Epidemiology Public Health

    May 1, 2020, 00:00

  • PMU60 DO COMPANIES SEQUENCE THE LAUNCH OF INDICATIONS FOR MULTI-INDICATION PRODUCTS?

    May 1, 2020, 00:00

  • PBI10 BUDGET IMPACT ANALYSIS OF MEPOLIZUMAB AS AN ADD-ON THERAPY IN THE TREATMENT OF SEVERE EOSINOPHILIC ASTHMA IN CHILE

    May 1, 2020, 00:00

  • PBI2 EFFICACY AND SAFETY OF BIOLOGICS FOR THE TREATMENT OF ADULT PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS IN RUSSIA: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

    May 1, 2020, 00:00

  • PCV84 BASELINE CHARACTERISTICS OF HEARTH FAILURE PATIENTS IN A PRIVATE PROVIDER IN CHILE

    May 1, 2020, 00:00

  • Cardiovascular Disorders - Real World Data Information Systems

    May 1, 2020, 00:00

  • PDB104 OPTIMIZATION OF INSULIN DOSE IN HOSPITALIZED PATIENTS WITH RECURRENT HYPOGLYCEMIA: REAL WORLD EXPERIENCE

    May 1, 2020, 00:00

  • PMH70 OVERVIEW OF INDIVIDUALS WITH ANXIETY DISORDERS IN THE U.S. AND TREATMENT PATTERNS IN ANTI-ANXIETY MEDICATION REGIMENS.

    May 1, 2020, 00:00

  • PMD34 DEEP JOINT INFECTION COMPARISON BETWEEN SIMULTANEOUS AND STAGED BILATERAL TOTAL KNEE ARTHROPLASTY

    May 1, 2020, 00:00

  • PMS65 A VISUAL ANALYTICAL APPROACH TO UNDERSTANDING TREATMENT PATTERNS AMONG TREATMENT-NAÏVE RHEUMATOID ARTHRITIS PATIENTS WITH BIOLOGIC USE IN THE US VETERANS HEALTH ADMINISTRATION DATABASE

    May 1, 2020, 00:00

  • Drugs Regulatory

    May 1, 2020, 00:00

  • PMU43 ASSOCIATION BETWEEN ATOPIC DISEASES AND ANEMIA IN KOREAN PATIENTS

    May 1, 2020, 00:00

  • Methods for Moving the Evaluation of Precision Medicine Into Practice and Policy

    May 1, 2020, 00:00

  • PDB47 ANNUAL HEALTH INSURANCE TREATMENT COST OF NON-INSULIN-DEPENDENT DIABETES WITH COMPLICATIONS BASED ON ROUTINELY COLLECTED FINANCING DATA

    May 1, 2020, 00:00

  • PDB99 BASELINE CHARACTERISTICS OF ENDOMETRIOSIS PATIENTS PARTICIPATING IN A REAL WORLD PROSPECTIVE COHORT STUDY: AN INTERIM ANALYSIS OF THE ELAGOLIX LONGITUDINAL OUTCOMES (LOTUS) STUDY

    May 1, 2020, 00:00

  • PMU26 COST-UTILITY ANALYSIS OF CANCER AND NON-CANCER CONDITIONS: A SYSTEMATIC REVIEW OF DIFFERENT LEVELS OF DISEASE PREVENTION AND CONTROL, 1990 TO 2016

    May 1, 2020, 00:00

  • PDB107 ASSESSING ASYMMETRICAL PRESCRIBING OF ANTIDIABETIC DRUGS RELATIVE TO DIAGNOSIS OF NAFLD

    May 1, 2020, 00:00

  • PGI16 BREAKDOWN OF COSTS ATTRIBUTABLE TO CLOSTRIDIOIDES DIFFICILE INFECTION IN THE US: RESULTS FROM A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00

  • PMD24 ANALYSIS OF THE COST-EFFECTIVENESS OF THE LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM AS ALTERNATIVE TO HISTERECTOMIES IN PRIVATE HEALTH INSURANCE IN BRAZIL

    May 1, 2020, 00:00

  • PIH72 PRENATAL MATERNAL STRESS CAN BE REDUCED BY MINDFULNESS TRAINING

    May 1, 2020, 00:00

  • PDG51 PREVALENCE AND RELATIVE PREDICTIVE VALUE OF DEMOGRAPHIC AND PAIN CHARACTERISTICS FOR OPIOID USE AMONG A NATIONAL SAMPLE OF COMMUNITY-BASED OLDER ADULTS WITH PAIN IN THE UNITED STATES

    May 1, 2020, 00:00

  • PMH39 ECONOMIC BURDEN ASSOCIATED WITH MAJOR DEPRESSIVE DISORDER, GLOBAL ANXIETY DISORDER, AND POLY-NONCOMMUNICABLE CHRONIC DISEASE (NCCD) COMORBIDITY

    May 1, 2020, 00:00

  • PDB9 THE COMPARATIVE EFFICACY OF ORAL SEMAGLUTIDE FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM): A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS (NMA)

    May 1, 2020, 00:00

  • PBI18 BIOLOGIC THERAPIES FOR MODERATE-TO-SEVERE PSORIASIS: COST PER RESPONDER ANALYSIS CONSIDERING PRIVATE HEALTHCARE SYSTEM IN BRAZIL

    May 1, 2020, 00:00

  • PMS75 PATIENT- AND PHYSICIAN-IDENTIFIED FACTORS GUIDING TREATMENT CHOICE IN KNEE OSTEOARTHRITIS AND PATIENT PREFERENCE FOR INTRA-ARTICULAR THERAPY

    May 1, 2020, 00:00

  • PIH29 ECONOMIC BURDEN OF ENDOMETRIOSIS: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2020, 00:00

  • PDB66 DEFINING DIABETES MELLITUS USING ADMINISTRATIVE CLAIMS DATA

    May 1, 2020, 00:00

  • Alternative Medicine Public Health

    May 1, 2020, 00:00

  • PIN34 COST-UTILITY ANALYSIS OF DIRECT ACTING ANTIVIRALS FOR EARLY-STAGE GENOTYPE 1 HCV PATIENTS IN BRAZIL

    May 1, 2020, 00:00

  • PIN78 CHARACTERIZATION OF UNNECESSARY EMERGENCY DEPARTMENT ENCOUNTERS FOR RABIES POSTEXPOSURE PROPHYLAXIS VACCINATION

    May 1, 2020, 00:00

  • PBI17 BUDGET IMPACT ANALYSIS OF INTRODUCTION OF RITUXIMAB BIOSIMILAR IN THE UNITED STATES FROM A PAYER PERSPECTIVE

    May 1, 2020, 00:00

  • PIH66 ASSOCIATION BETWEEN MEDICATION BURDEN AND ADHD MEDICATION ADHERENCE IN A PEDIATRIC POPULATION WITH MULTIPLE CHRONIC CONDITIONS

    May 1, 2020, 00:00

  • PMH36 THE RELATIONSHIP BETWEEN IRON DEFICIENCY ANAEMIA AND ANTENATAL DEPRESSION AMONG PREGNANT WOMEN

    May 1, 2020, 00:00

  • PMU3 EFFECTIVENESS OF IMPLEMENTATION OF ANTIMICROBIAL STEWARDSHIP PROGRAMMES IN INDIA: EVIDENCE FROM SYSTEMATIC REVIEW AND META-ANALYSIS

    May 1, 2020, 00:00

  • PMU30 COST-EFFECTIVENESS ANALYSIS OF NEWBORN SCREENING FOR SPINAL MUSCULAR ATROPHY (SMA) IN THE UNITED STATES

    May 1, 2020, 00:00

  • PDB11 THE PERINATAL OUTCOMES AMONG WOMEN WITH TWIN PREGNANCIES: PROPENSITY SCORE MATCHED ANALYSIS FROM A SEVEN-YEAR RETROSPECTIVE COHORT

    May 1, 2020, 00:00

  • PMH16 DRUG EXPENDITURE, PRICE, AND UTILIZATION IN THE U.S. MEDICAID PROGRAM: AN EMPIRICAL TREND ANALYSIS FOR SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) AND SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIS) ANTIDEPRESSANTS FROM 1991 ...

    May 1, 2020, 00:00

  • PMH34 INTEGRATING COUNTY-LEVEL HEALTH, HUMAN SERVICES, AND CRIMINAL JUSTICE DATA TO PREDICT RISK OF OPIOID OVERDOSE AMONG MEDICAID BENEFICIARIES: A MACHINE LEARNING APPROACH

    May 1, 2020, 00:00

  • PMS57 EPIDEMIOLOGIC MODELING TO GUIDE PAYER DECISIONS IN RARE DISEASES: A CASE STUDY OF DUCHENNE MUSCULAR DYSTROPHY IN THE UNITED STATES

    May 1, 2020, 00:00

  • PDB46 ELEVATED ANNUAL HEALTHCARE UTILIZATION AND DIRECT MEDICAL COSTS ASSOCIATED WITH DIABETES MELLITUS PATIENTS WITH OSTEOPOROSIS IN CHINA

    May 1, 2020, 00:00

  • PMD48 ROBOTIC TOTAL HYSTERECTOMY: ASSOCIATION OF SURGICAL INDICATION WITH USE OF ROBOTIC-ASSISTANCE AND RELATED HEALTHCARE RESOURCE UTILIZATION AND COSTS

    May 1, 2020, 00:00

  • PIH24 A CLINICAL AND ECONOMIC EVALUATION OF SURFACTANT THERAPY FOR MECONIUM ASPIRATION SYNDROME IN THE NEONATAL INTENSIVE CARE SETTING IN QATAR

    May 1, 2020, 00:00

  • PIH53 PHARMACISTS' INTERVENTIONS IN TRANSITIONS OF CARE: EVALUATING THE FINANCIAL AND CLINICAL IMPLICATIONS FOR LONG-TERM CARE

    May 1, 2020, 00:00

  • PIH59 ADHERENCE TO TREATMENT FOR POLYCYSTIC OVARIAN SYNDROME: A SYSTEMATIC REVIEW

    May 1, 2020, 00:00

  • PDB63 MULTIMORBIDTY AND FIVE-YEAR TREND IN DIABETES CARE MANAGEMENT (DCM) AMONG ADULTS WITH DIABETES

    May 1, 2020, 00:00

  • Biologics/Biosimilars/Regenerative Medicine - Health Technology Assessment

    May 1, 2020, 00:00

  • PIN56 VACCINE EXPOSURE DURING PREGNANCY AMONG PRIVATELY AND PUBLICLY INSURED WOMEN IN THE UNITED STATES

    May 1, 2020, 00:00

  • PMU28 CLINICAL AND ECONOMIC OUTCOMES OF CARBAPENEM-RESISTANT GRAM-NEGATIVE ORGANISMS: A MULTICENTER STUDY IN CHINA

    May 1, 2020, 00:00

  • PMU50 CHARACTERIZATION AND TRENDS OF MATERNAL MORTALITY IN TWO TERTIARY HOSPITALS IN NIGERIA: WHY DID THEY DIE?

    May 1, 2020, 00:00

  • Infectious Diseases - Medical Technologies

    May 1, 2020, 00:00

  • PGI23 TREATMENT COST ANALYSIS FOR PATIENTS IN THE UNITED STATES WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS WHO HAVE AN INADEQUATE RESPONSE OR WHO ARE INTOLERANT TO TNF BLOCKERS

    May 1, 2020, 00:00

  • PMH45 DISPARITIES IN TREATMENT ADMISSIONS FOR OPIOID USE DISORDER IN CINCINNATI BY RACE

    May 1, 2020, 00:00

  • PMS62 EPIDEMIOLOGICAL DISEASE BURDEN OF INJURIES TO THE WRIST AND HAND BASED ON ROUTINELY COLLECTED HEALTH INSURANCE CLAIMS DATA

    May 1, 2020, 00:00

  • PMD15 ASSESSMENT OF THE RISK AND ECONOMIC BURDEN OF SURGICAL SITE INFECTION FOLLOWING COLORECTAL SURGERY USING A US LONGITUDINAL DATABASE: IS THERE A ROLE FOR INNOVATIVE ANTIMICROBIAL WOUND CLOSURE TECHNOLOGY TO REDUCE THE RISK OF INFECTION ...

    May 1, 2020, 00:00

  • PIN70 COST OF BLOOD AND BODY FLUID OCCUPATIONAL EXPOSURE MANAGEMENT IN CHINA

    May 1, 2020, 00:00

  • PCV64 IMPACT ON ANTIHYPERTENSIVE PRESCRIBING AFTER THE DEAR HEALTHCARE PROFESSIONAL LETTER ON INCREASED RISK OF SKIN CANCER RELATED TO HYDROCHLOROTHIAZIDE

    May 1, 2020, 00:00

  • Mental Health - Economic Evaluation

    May 1, 2020, 00:00

  • Investigation Into the Effects of Using Normal Distribution Theory Methodology for Likert Scale Patient-Reported Outcome Data From Varying Underlying Distributions Including Floor/Ceiling Effects

    May 1, 2020, 00:00

  • PMU11 ASSOCIATION BETWEEN DEPRESSION AND HEALTHCARE EXPENDITURES AMONG STROKE SURVIVORS

    May 1, 2020, 00:00

  • PMU52 CLINICAL ADOPTION OF GENOMIC TESTING IN ONCOLOGY: A TARGETED LITERATURE REVIEW OF THE GLOBAL PAYER LANDSCAPE

    May 1, 2020, 00:00

  • PMD5 COMPARATIVE EFFECTIVENESS ASSESSMENT OF TWO POWERED SURGICAL STAPLING PLATFORMS IN LAPAROSCOPIC SLEEVE GASTRECTOMY

    May 1, 2020, 00:00

  • PDB42 BUDGET IMPACT ANALYSIS OF SENSOR-AUGMENTED PUMP IN TYPE 1 DIABETES MELLITUS COMPARED WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN THE RUSSIAN FEDERATION

    May 1, 2020, 00:00

  • PIH35 LONG-TERM PRESCRIPTION OPIOID USE AMONG OLDER ADULTS IN THE UNITED STATES

    May 1, 2020, 00:00

  • PIH69 THE NEED FOR PERSON-CENTRED CARE IN ENDOMETRIOSIS TREATMENT: QUALITATIVE INSIGHTS AND DISCRETE CHOICE EXPERIMENT DEVELOPMENT

    May 1, 2020, 00:00

  • PDB75 EFFECT OF CHRONIC EXPOSURE TO PSYCHOTROPIC MEDICATION ON THE INCIDENCE OF NEW-ONSET TYPE 2 DIABETES MELLITUS IN ADULTS, A RETROSPECTIVE COHORT STUDY USING PRESCRIPTION CLAIMS FROM COLOMBIA

    May 1, 2020, 00:00

  • PMH35 MENTAL AND BEHAVIORAL DISORDERS DUE TO OPIOID USE IN COLOMBIA: PREVALENCE AND DEMOGRAPHIC CHARACTERISTICS 2009-2018

    May 1, 2020, 00:00

  • PIH31 INVERSE RELATIONSHIP BETWEEN ANEMIA IN THE THIRD TRIMESTER OF PREGNANCY AND LOW BIRTH WEIGHT IN A REFERENCE MATERNITY UNIT OF A CARRIBEAN REGION OF COLOMBIA

    May 1, 2020, 00:00

  • PMD47 THE CHOICES COMPARATIVE TRIAL: FACILITY COST AND OUTCOMES ANALYSIS OF MYOMECTOMY COMPARED TO TREATMENT WITH THE SONATA SYSTEM

    May 1, 2020, 00:00

  • PDG40 TRENDS IN UTILIZATION, REIMBURSEMENT, AND PRICE FOR ANTICOAGULANTS IN THE US MEDICAID POPULATION FROM 2000 TO 2018

    May 1, 2020, 00:00

  • PIH4 NUMBER NEEDED TO TREAT (NNT) WITH FENFLURAMINE TO ACHIEVE A CLINICALLY MEANINGFUL REDUCTION IN CONVULSIVE SEIZURE FREQUENCY IN PATIENTS WITH DRAVET SYNDROME: HEALTH ECONOMIC IMPLICATIONS

    May 1, 2020, 00:00

  • PMS40 REAL-WORLD TREATMENT PATTERNS AND ECONOMIC BURDEN OF ROTATOR CUFF TEAR PATIENTS IN THE US

    May 1, 2020, 00:00

  • PBI19 BUDGET IMPACT ANALYSIS OF IXEKIZUMAB, GUSELKUMAB, RISANKIZUMAB AND/OR SECUKINUMAB FOR MANAGEMENT OF MODERATE-TO-SEVERE PSORIASIS IN THE KINGDOM OF SAUDI ARABIA

    May 1, 2020, 00:00

  • Individual's Health - Health Technology Assessment

    May 1, 2020, 00:00

  • PDB93 NAFLD SIMULATOR: A WEB-BASED SIMULATION TOOL TO PREDICT LONG-TERM OUTCOMES OF NON-ALCOHOLIC FATTY LIVER DISEASE

    May 1, 2020, 00:00

  • PDB32 COST-EFFECTIVENESS OF ONCE-WEEKLY SEMAGLUTIDE 1 MG VS. CANAGLIFLOZIN 300 MG IN PATIENTS WITH TYPE 2 DIABETES IN A CANADIAN SETTING

    May 1, 2020, 00:00

  • PMH67 CAPTURING PATIENT EXPERIENCE AS A KEY TO BETTER OUTCOMES: THE IMPORTANCE OF COGNITIVE APPRAISAL PROCESSES IN ENABLING RESILIENCE AMONG DEPRESSED INDIVIDUALS

    May 1, 2020, 00:00

  • PMU47 NOSOCOMIAL INFLUENZA HOSPITALIZATIONS AMONG END-STAGE RENAL DISEASE PATIENTS DURING THE 2013-2014 THROUGH 2015-2016 INFLUENZA SEASONS

    May 1, 2020, 00:00
  • «
  • 41
  • 42
  • 43 (current)
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • »